Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1999 | 12-1998 | 09-1998 | 06-1998 | 03-1998 | |
| Sales | 1,193 | 993 | 419 | 765 | 460 |
| Cost of Goods | 460 | 430 | 430 | 600 | 440 |
| Gross Profit | 530 | -10 | -10 | -140 | 540 |
| Operating Expenses | 760 | 700 | 700 | 870 | 940 |
| Operating Income | 433 | 293 | -281 | -105 | -480 |
| Interest Expense | 2 | 2 | 2 | 2 | 10 |
| Other Income | -201 | -601 | -27 | -273 | 560 |
| Pre-tax Income | 230 | -310 | -310 | -380 | 70 |
| Net Income Continuous | 409 | 239 | -315 | -346 | -388 |
| Net Income | $409 | $239 | $-315 | $-346 | $-388 |
| EPS Basic Total Ops | 0.07 | 0.04 | -0.05 | -0.06 | -0.06 |
| EPS Basic Continuous Ops | 0.07 | 0.04 | -0.05 | -0.06 | -0.06 |
| EPS Diluted Total Ops | 0.07 | 0.04 | -0.05 | -0.06 | -0.06 |
| EPS Diluted Continuous Ops | 0.07 | 0.04 | -0.05 | -0.06 | -0.06 |
| EBITDA(a) | $533 | $73 | $-221 | $-45 | $-330 |